A-Alpha Bio
A-Alpha Bio is a biotechnology company focused on accelerating therapeutic discovery by measuring, predicting, and engineering protein-protein interactions at scale. They leverage synthetic biology and machine learning through their proprietary platforms, AlphaSeq and AlphaBind. AlphaSeq is a high-throughput platform for quantitative characterization of protein-protein interactions, generating the world's largest repository of such data. AlphaBind uses this data to predict binding from protein sequence. A-Alpha Bio applies these technologies to internal therapeutic programs and partners with pharmaceutical companies to discover and develop novel therapeutics, including biologics and molecular glues.
A-Alpha Bio
A-Alpha Bio is a biotechnology company focused on accelerating therapeutic discovery by measuring, predicting, and engineering protein-protein interactions at scale. They leverage synthetic biology and machine learning through their proprietary platforms, AlphaSeq and AlphaBind. AlphaSeq is a high-throughput platform for quantitative characterization of protein-protein interactions, generating the world's largest repository of such data. AlphaBind uses this data to predict binding from protein sequence. A-Alpha Bio applies these technologies to internal therapeutic programs and partners with pharmaceutical companies to discover and develop novel therapeutics, including biologics and molecular glues.